{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:51:32Z","timestamp":1790146292420,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"China TB Control Program of Global Fund","award":["CHN-S10-G14-T"],"award-info":[{"award-number":["CHN-S10-G14-T"]}]},{"name":"The Science and Technology Program Of The Health and Family Planning Commission of Wuhan Municipality","award":["WX13B22"],"award-info":[{"award-number":["WX13B22"]}]},{"name":"The Program of Wuhan Municipal Science and Technology Bureau","award":["201406280101265"],"award-info":[{"award-number":["201406280101265"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2409-6","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T10:56:59Z","timestamp":1493031419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing"],"prefix":"10.1186","volume":"17","author":[{"given":"Jun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"2409_CR1","unstructured":"World Health Organization. Global tuberculosis report 2015. 20th edn. Geneva: World Health Organization; 2015."},{"issue":"23","key":"2409_CR2","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161\u201370.","journal-title":"N Engl J Med"},{"issue":"6","key":"2409_CR3","doi-asserted-by":"publisher","first-page":"e39754","DOI":"10.1371\/journal.pone.0039754","volume":"7","author":"S Malik","year":"2012","unstructured":"Malik S, Willby M, Sikes D, Tsodikov OV, Posey JE. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations. Plos One. 2012;7(6):e39754.","journal-title":"Plos One"},{"issue":"6","key":"2409_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3201\/eid2106.141907","volume":"21","author":"SE Smith","year":"2015","unstructured":"Smith SE, Ershova J, Vlasova N, Nikishova E, Tarasova I, Eliseev P, Maryandyshev AO, Shemyakin IG, Kurbatova E, Cegielski JP. Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk oblast, Russia, 2005-2010. Emerg Infect Dis. 2015;21(6):1002\u201311.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2409_CR5","doi-asserted-by":"publisher","first-page":"e0117421","DOI":"10.1371\/journal.pone.0117421","volume":"10","author":"N Selvakumar","year":"2015","unstructured":"Selvakumar N, Kumar V, Balaji S, Prabuseenivasan S, Radhakrishnan R, Sekar G, Chandrasekaran V, Kannan T, Thomas A, Arunagiri S, et al. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. Plos One. 2015;10(3):e0117421.","journal-title":"Plos One"},{"issue":"3","key":"2409_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tube.2014.03.005","volume":"94","author":"H Wang","year":"2014","unstructured":"Wang H, Zhang X, Luo T, Li X, Tian P, Xu Y, Gao Q. Prediction of XDR\/pre-XDR tuberculosis by genetic mutations among MDR cases from a hospital in Shandong, China. Tuberculosis. 2014;94(3):277\u201381.","journal-title":"Tuberculosis"},{"issue":"3","key":"2409_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3201\/eid1703.100919","volume":"17","author":"S Tang","year":"2011","unstructured":"Tang S, Zhang Q, Yu J, Liu Y, Sha W, Sun H, Fan L, Gu J, Hao X, Yao L, et al. Extensively drug-resistant tuberculosis, China. Emerg Infect Dis. 2011;17(3):558\u201360.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"2409_CR8","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1128\/JCM.00521-07","volume":"45","author":"D Hillemann","year":"2007","unstructured":"Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2007;45(8):2635\u201340.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2409_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3164\/jcbn.2008033","volume":"42","author":"Y Shimizu","year":"2008","unstructured":"Shimizu Y, Dobashi K, Yoshikawa Y, Yabe S, Higuchi S, Koike Y, Mita Y, Utsugi M, Endou K, Takahashi K, et al. Five-antituberculosis drug-resistance genes detection using Array system. J Clin Biochem Nutr. 2008;42(3):228\u201334.","journal-title":"J Clin Biochem Nutr"},{"issue":"1","key":"2409_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/JCM.01463-09","volume":"48","author":"D Helb","year":"2010","unstructured":"Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229\u201337.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2409_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.diagmicrobio.2012.06.013","volume":"74","author":"DA Williamson","year":"2012","unstructured":"Williamson DA, Basu I, Bower J, Freeman JT, Henderson G, Roberts SA. An evaluation of the Xpert MTB\/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis. 2012;74(2):207\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"2409_CR12","doi-asserted-by":"publisher","first-page":"e90569","DOI":"10.1371\/journal.pone.0090569","volume":"9","author":"O Ocheretina","year":"2014","unstructured":"Ocheretina O, Escuyer VE, Mabou MM, Royal-Mardi G, Collins S, Vilbrun SC, Pape JW, Fitzgerald DW. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. Plos One. 2014;9(3):e90569.","journal-title":"Plos One"},{"issue":"4","key":"2409_CR13","doi-asserted-by":"publisher","first-page":"e0152694","DOI":"10.1371\/journal.pone.0152694","volume":"11","author":"A Rahman","year":"2016","unstructured":"Rahman A, Sahrin M, Afrin S, Earley K, Ahmed S, Rahman SM, Banu S. Comparison of Xpert MTB\/RIF assay and GenoType MTBDRplus DNA probes for detection of mutations associated with Rifampicin resistance in Mycobacterium tuberculosis. Plos One. 2016;11(4):e0152694.","journal-title":"Plos One"},{"issue":"12","key":"2409_CR14","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1128\/JCM.01506-06","volume":"44","author":"A Somoskovi","year":"2006","unstructured":"Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol. 2006;44(12):4459\u201363.","journal-title":"J Clin Microbiol"},{"key":"2409_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012;13:134.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"2409_CR16","first-page":"e2","volume":"6","author":"A Sandgren","year":"2009","unstructured":"Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. Tuberculosis drug resistance mutation database. Plos One. 2009;6(2):e2.","journal-title":"Plos One"},{"issue":"2","key":"2409_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1128\/JCM.01821-13","volume":"52","author":"SY Lin","year":"2014","unstructured":"Lin SY, Rodwell TC, Victor TC, Rider EC, Pham L, Catanzaro A, Desmond EP. Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol. 2014;52(2):475\u201382.","journal-title":"J Clin Microbiol"},{"key":"2409_CR18","first-page":"207","volume":"6","author":"F Zakham","year":"2013","unstructured":"Zakham F, Chaoui I, Echchaoui AH, Chetioui F, Elmessaoudi MD, Ennaji MM, Abid M, Mzibri ME. Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco. Infect Drug Resist. 2013;6:207\u201313.","journal-title":"Infect Drug Resist"},{"key":"2409_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1471-2334-14-200","volume":"14","author":"R Zheng","year":"2014","unstructured":"Zheng R, Zhu C, Guo Q, Qin L, Wang J, Lu J, Cui H, Cui Z, Ge B, Liu J, et al. Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients. BMC Infect Dis. 2014;14:200.","journal-title":"BMC Infect Dis"},{"key":"2409_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12916-016-0575-9","volume":"14","author":"J Phelan","year":"2016","unstructured":"Phelan J, Coll F, McNerney R, Ascher DB, Pires DE, Furnham N, Coeck N, Hill-Cawthorne GA, Nair MB, Mallard K, et al. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. BMC Med. 2016;14:31.","journal-title":"BMC Med"},{"issue":"3","key":"2409_CR21","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1128\/AAC.00964-09","volume":"54","author":"T Luo","year":"2010","unstructured":"Luo T, Zhao M, Li X, Xu P, Gui X, Pickerill S, DeRiemer K, Mei J, Gao Q. Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. Antimicrob Agents Chemother. 2010;54(3):1075\u201381.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2409_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1054\/tuld.1999.0231","volume":"80","author":"P Kiepiela","year":"2000","unstructured":"Kiepiela P, Bishop KS, Smith AN, Roux L, York DF. Genomic mutations in the katG, inhA and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis. 2000;80(1):47\u201356.","journal-title":"Tuber Lung Dis"},{"issue":"1","key":"2409_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/AAC.03614-14","volume":"59","author":"K Ajbani","year":"2015","unstructured":"Ajbani K, Lin SY, Rodrigues C, Nguyen D, Arroyo F, Kaping J, Jackson L, Garfein RS, Catanzaro D, Eisenach K, et al. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. Antimicrob Agents Chemother. 2015;59(1):414\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2409_CR24","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1128\/AAC.01550-10","volume":"55","author":"PJ Campbell","year":"2011","unstructured":"Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011;55(5):2032\u201341.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2409_CR25","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1128\/JCM.00515-06","volume":"44","author":"X Ma","year":"2006","unstructured":"Ma X, Wang H, Deng Y, Liu Z, Xu Y, Pan X, Musser JM, Graviss EA. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol. 2006;44(9):3409\u201312.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2409_CR26","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1128\/JCM.41.5.2209-2212.2003","volume":"41","author":"J Yue","year":"2003","unstructured":"Yue J, Shi W, Xie J, Li Y, Zeng E, Wang H. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Clin Microbiol. 2003;41(5):2209\u201312.","journal-title":"J Clin Microbiol"},{"key":"2409_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2180-12-90","volume":"12","author":"S Feuerriegel","year":"2012","unstructured":"Feuerriegel S, Oberhauser B, George AG, Dafae F, Richter E, Rusch-Gerdes S, Niemann S. Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. BMC Microbiol. 2012;12:90.","journal-title":"BMC Microbiol"},{"issue":"8","key":"2409_CR28","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1128\/AAC.00112-06","volume":"50","author":"MH Hazbon","year":"2006","unstructured":"Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, Garcia-Garcia L, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2006;50(8):2640\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2409_CR29","doi-asserted-by":"publisher","first-page":"e0119628","DOI":"10.1371\/journal.pone.0119628","volume":"10","author":"M Seifert","year":"2015","unstructured":"Seifert M, Catanzaro D, Catanzaro A, Rodwell TC. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. Plos One. 2015;10(3):e0119628.","journal-title":"Plos One"},{"issue":"2","key":"2409_CR30","first-page":"136","volume":"16","author":"J Chen","year":"2012","unstructured":"Chen J, Chen Z, Li Y, Xia W, Chen X, Chen T, Zhou L, Xu B, Xu S. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China. Braz J Infect Dis. 2012;16(2):136\u201341.","journal-title":"Braz J Infect Dis"},{"issue":"10","key":"2409_CR31","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/AAC.00287-09","volume":"53","author":"A Von Groll","year":"2009","unstructured":"Von Groll A, Martin A, Jureen P, Hoffner S, Vandamme P, Portaels F, Palomino JC, da Silva PA. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother. 2009;53(10):4498\u2013500.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2409_CR32","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1128\/AAC.00036-08","volume":"52","author":"I Mokrousov","year":"2008","unstructured":"Mokrousov I, Otten T, Manicheva O, Potapova Y, Vishnevsky B, Narvskaya O, Rastogi N. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother. 2008;52(8):2937\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2409_CR33","doi-asserted-by":"publisher","first-page":"e0120470","DOI":"10.1371\/journal.pone.0120470","volume":"10","author":"E Avalos","year":"2015","unstructured":"Avalos E, Catanzaro D, Catanzaro A, Ganiats T, Brodine S, Alcaraz J, Rodwell T. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review. Plos One. 2015;10(3):e0120470.","journal-title":"Plos One"},{"issue":"3","key":"2409_CR34","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1128\/AAC.04058-14","volume":"59","author":"C Bernard","year":"2015","unstructured":"Bernard C, Veziris N, Brossier F, Sougakoff W, Jarlier V, Robert J, Aubry A. Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2015;59(3):1519\u201324.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2409_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000109769","volume":"53","author":"I Escribano","year":"2007","unstructured":"Escribano I, Rodriguez JC, Llorca B, Garcia-Pachon E, Ruiz M, Royo G. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy. 2007;53(6):397\u2013401.","journal-title":"Chemotherapy"},{"issue":"2","key":"2409_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jinf.2010.05.001","volume":"61","author":"X Yin","year":"2010","unstructured":"Yin X, Yu Z. Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J Infect. 2010;61(2):150\u20134.","journal-title":"J Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2409-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T10:57:29Z","timestamp":1493031449000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2409-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2409"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2409-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"article-number":"300"}}